CISPLATIN and PYREXIA

Overview

PYREXIA is the #10 most commonly reported adverse reaction for CISPLATIN, manufactured by Accord Healthcare Inc.. There are 3,314 FDA adverse event reports linking CISPLATIN to PYREXIA. This represents approximately 2.4% of all 137,577 adverse event reports for this drug.

Patients taking CISPLATIN who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for CISPLATIN, but still significant enough to appear in the safety profile.

Other Side Effects of CISPLATIN

In addition to pyrexia, the following adverse reactions have been reported for CISPLATIN:

• OFF LABEL USE — 5,579 reports
• NAUSEA — 5,289 reports
• NEUTROPENIA — 4,712 reports
• DISEASE PROGRESSION — 4,530 reports
• VOMITING — 4,446 reports
• FEBRILE NEUTROPENIA — 4,406 reports
• ANAEMIA — 3,874 reports
• DIARRHOEA — 3,679 reports
• THROMBOCYTOPENIA — 3,652 reports
• DRUG INEFFECTIVE — 3,199 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CISPLATIN cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,314 FDA reports for CISPLATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CISPLATIN?

PYREXIA accounts for approximately 2.4% of all adverse event reports for CISPLATIN, making it a notable side effect.

What should I do if I experience PYREXIA while taking CISPLATIN?

If you experience pyrexia while taking CISPLATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages